Our first Institutional Insights video series is now available! "Empowering Early Intervention: Navigating Treatments for Delaying T1D Progression," features insights from experts in diabetes management from Albany Medical Center who are using teplizumab with young patients to delay progression of type 1 diabetes from type 1 stage 2 to type 1 stage 3, or frank diabetes. They discuss type 1 diabetes screening, staging, and appropriate follow-up; explore the teplizumab mechanism of action; look at location options for infusion, and more. https://lnkd.in/eiymhTgN
Patient Care Online’s Post
More Relevant Posts
-
Reduce the risk of amputations from diabetic peripheral neuropathy (DPN) with early detection and proactive care. Improve patient outcomes by perfecting your foot exam techniques for people with diabetes. Learn how at bit.ly/4aDJyNn.
To view or add a comment, sign in
-
-
Revolution in Diabetes Care: Clinical Trial Highlights New Blood Sugar Lowering Strategy Discover the breakthrough that's making headlines! A new clinical trial offers hope for Type 2 diabetics by significantly lowering blood sugar levels. 🌟 This research not only provides new insights into diabetes treatment but also highlights the potential for less invasive solutions in the future. Could this be the answer many have been waiting for? Check out our full video for a deep dive into the trial's methods, results, and what it means for the future of diabetes treatment. #BreakingNews #DiabetesResearch #HealthcareEvolution #BloodSugarControl
To view or add a comment, sign in
-
Take the first steps to support monitoring the precision of HbA1c test methods associated with diabetes to your QC workflow with Bio-Rad's Liquichek Diabetes Controls. With a 3 year shelf life, long open-vial stability and 3 distinct levels to help monitor precision of HbA1c test methods, Bio-Rad is here to help you with your diabetes testing needs so you can focus on what matters: improving quality of patient care. Learn More: https://bit.ly/416Cplo #QualityControl #ClinicalLaboratory #ClinicalDiagnostics
Diabetes Quality Controls
qcnet.com
To view or add a comment, sign in
-
💡 Did you know up to 70% of people with diabetes will be affected by diabetic peripheral neuropathy, and nearly half have no symptoms to alert them that it’s happening. This often silent condition increases the risk of foot ulcers and potential amputations. The journey to diagnosing diabetic peripheral neuropathy needs to change for both patients and providers. Learn more ➡ https://bit.ly/3RhmDkr 🔎 Discover how Body Pro 2 is revolutionizing diabetes care with Electrochemical Skin Conductance, the first-ever, at-home, prescription-only (Rx) measurement to aid care teams in the assessment of a patient's risk for diabetic foot ulcers.
Fill the Diabetes Care Gap with Body Pro 2 - the first-ever cellular scale to go beyond weight
To view or add a comment, sign in
-
How can individualized management strategies reduce long-term complications and improve outcomes in patients with type 2 diabetes? In this educational program, Drs. Jennifer Green and Tina Thethi explore the importance of tailoring type 2 diabetes treatment to individual patient needs, including key considerations for selecting incretin-based therapies and the impact of weight loss on glycemic control. Their discussion illuminates the importance of a holistic, patient-centric approach in diabetes care, emphasizing shared decision-making and the incorporation of lifestyle modifications alongside pharmacological interventions. They also examine the concept of therapeutic inertia and its impact on diabetes management, emphasizing the importance of regular, proactive regimen evaluations to prevent long-term complications. Explore the importance of personalized care in type 2 diabetes management: https://ow.ly/j1vh50QFK8x #PatientCenteredCare #IncretinTherapies #DiabetesManagement
Are You Seeing the Whole Picture? Case Reviews of Therapy Intensification for Patients with Type 2 Diabetes
To view or add a comment, sign in
-
If you have a child with Type 1 Diabetes and that kid has siblings, have the siblings participate in TrialNet (https://www.trialnet.org/). It is a blood test to determine if siblings will get Type 1 Diabetes.
Imagine a future without type 1 diabetes
trialnet.org
To view or add a comment, sign in
-
How can individualized management strategies reduce long-term complications and improve outcomes in patients with type 2 diabetes? In this educational program, Drs. Jennifer Green and Tina Thethi explore the importance of tailoring type 2 diabetes treatment to individual patient needs, including key considerations for selecting incretin-based therapies and the impact of weight loss on glycemic control. Their discussion illuminates the importance of a holistic, patient-centric approach in diabetes care, emphasizing shared decision-making and the incorporation of lifestyle modifications alongside pharmacological interventions. They also examine the concept of therapeutic inertia and its impact on diabetes management, emphasizing the importance of regular, proactive regimen evaluations to prevent long-term complications. Explore the importance of personalized care in type 2 diabetes management: https://ow.ly/2nHT50QFK5P #PatientCenteredCare #IncretinTherapies #DiabetesManagement
Are You Seeing the Whole Picture? Case Reviews of Therapy Intensification for Patients with Type 2 Diabetes
To view or add a comment, sign in
-
Endocrinologist, Epidemiologist, Researcher, HCP Educator, Guidelines chair, Public health expert, Philanthropist
In this Diabetes Care publication, we take a deep-dive into CGM data from two once-weekly icodec trials to answer pertinent clinical questions. Specifically, the hypoglycemia results are highly reassuring, given the context that the ONWARDS 2 and 4 trials included people with longstanding type 2 diabetes switching from basal alone or basal-bolus regimen ie those who would be deemed to be at high risk for hypoglycemia. Here's the free link to the full publication https://lnkd.in/gpqzPUYB
To view or add a comment, sign in
-
Final results from the prevalence phase of our phase IV clinical trial study of hypercortisolism (Cushing’s syndrome) in patients with difficult-to-control type 2 diabetes were presented today at the American Diabetes Association 84th Scientific Sessions. Read more: https://lnkd.in/g_SbwHCT #CortisolModulation #Diabetes #Type2Diabetes #ADASciSessions #Hypercortisolism
To view or add a comment, sign in
-